Colon Flashcards
The parts that are covered by Serosa (peritoneum):
Cecum Transverse Sigmoid Ant. Ascending Ant. Descending Rectosigmoid Upper 3rd and ant. Wall of middle third of rectum
Parts without serosa :
Post. Ascending
Post. Descending
Lower 3rd of rectum
IBD - inflamatory bowel disease
2 major disorders :
1) ulcerative colitis ( uc)
2) cronh’s disease
Crohn’s disease :
Causes inflammation of the digestive system
-Can affect any area from the mouth to the anus , it often affects the ileum.
Its aspect feature is cobblestones , and it does not affect in a continuous way
-Smoking worsen the disease
-crohns disease usually affects the entire thickness
-bowel obstruction, fistulas can appear
Etiologic theories of IBD:
- genetic predisposition
- mucosal immune system
- enviromental triggers (bacteria , infection, NSAID, smoking)
Sympts. Of ulcerative colitis ;
- altered bowel movements: ⬆️stool frequency ⬇️stool cosistency -abdominal pain: LLQ cramping , relieved with defecation Tenesmus ( the feeling of the need to pass stool even if its empty) -blood 🩸 in stool
Sympts. Of Crohn’s disease :
- chronic or nocturnal diarrhea
- abd. Pain
- distension and postprandial RLQ abd. Pain
- weight loss
- fever
- rectal bleeding
Risk factors for a more severe Crohn’s disease:
- early age at diagnosis <40
- perisnal involvment
- severe deep ulceration on endoscopy
- multiple areas of involvement
- current tabacco use
Risk factors for severe ulcerative colitis:
- early age at diagnosis <40
- early steroid treatment
- extensive colitis
- hospitalization
- elevated inflammatory markers ( CRP, ESR)
- low serum albumin
Anti- TNF agents are:
✅Infliximab ✅Adalimumab Golimumab(uc) Gertolizumab (cd) Pegol (cd)
Anti- integin Agents:
✅Vedolizumab
Natalizumab (cd)
Medications for active disease (UC):
1) 5-Aminosalicylic acid derivatives:
Sulfasalazine, mesalamine, balsalazide, olsalazine
2) ANTBX: metronidazole, ciprofloxaxin,rifaximin
3)corticosteroids:
Hydrocortisone, prednisone, methylprednisolone, predinsolone , budesonide, dexamethasone
4)immunomodulators:
Azathioprine, 6-mercaptopurine, methotrexate, cyclosporine
5) TNF inhibitors:
Infliximab, adalimumab , certolizumab pegol , golimumab
6)anti-integrin agents:
Natalizumab, vedolizumab
7) Anti-IL12/23 agents:
Ustekinumab
Drugs for sympt, relief :
-antidiarrheal : diphenoxylate and atropine, loperamide, cholysteramine
-Anticholinergic antispasmodic agents:
Dicyclomine, hyocyamine
Dermatological manifestation in IBD:
▪️erythema nodosum:
CD>UC, most common manifes.
▪️skin cancer
▪️pyoderma gangrenosum: most common site is legs
▪️psoriasis, sweet’s syndrome, metastatic croh’s disease
Musculoskeletal manifestations of IBD:
▪️peripheral arthritis
▪️spondylitis
▪️sacroilitis
Ocular manifestation in IBD:
▪️Episcleritis (ant. Chamber)
▪️post chamber: uveitis
▪️cataract ( from steroid treatment
Other manifestations in IBD:
▪️thrombosis (hypercoagulable state)
▪️primary sclerosing cholangitis , fatty liver , gallstones
▪️Aphthous stomatitis ( repeated formation of benign and non contagious mouth ulcers
▪️Nephrolithiasis , obst. Uropathy , urinary tract fistulization
▪️colorectal cancer risk ( >8 years duration of disease , family history of CRC, psc
Toxic megacolon:
Ineffective peristalsis (paralysis of myenteric plexus)
Distention leads to perforation
Sepsis and death
-dilatation >5.5cm on roentgenography
+3/4 of : fever , tachcard, leukocytosis , anemia